Inactive Instrument

UNIL HEALNPV Stock Hong Kong S.E.

2988

KYG9302L1361

Universal Health International Group Holding Ltd is an investment holding primarily engaged in the distribution and retail of drugs, healthcare products and other pharmaceutical products. The Company operates its businesses through three segments. The Distribution segment is primarily engaged in the distribution of drugs and other pharmaceutical products to pharmaceutical retailers, hospitals, clinics and distributors. The Retail segment is primarily engaged in the retail of drugs and other pharmaceutical products through a chain of retail pharmacies. The Others segment is primarily engaged in investment business. The Companyâ€™s products primarily include prescribed drugs, non-prescribed drugs, healthcare products and other pharmaceutical products. The Company primarily operates its businesses in the domestic market.

Employees

665

Sector

Drug Retailers

More about the company

As early as today, start finding the best investment opportunities!

Market Cap	43.57M 50.68M 6.46M 5.58M 5.25M 4.77M 8.97M 619M 9.11M 61.59M 24.14M 310M 24.26M 23.73M 1.03B	P/E 2024	110x	P/E 2025	-3.29x
Enterprise Value	54.71M 63.64M 8.11M 7.01M 6.59M 5.99M 11.27M 777M 11.43M 77.33M 30.31M 389M 30.46M 29.8M 1.29B	EV / Sales 2024	0.08x	EV / Sales 2025	0.14x
Free-Float	90.52%	Yield 2024 *	-	Yield 2025	-

02-27	Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
25-09-30	Universal Health International Group Holding Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
25-09-30	Universal Health International Forecasts Fiscal 2025 Loss	MT
25-09-29	Universal Health International expects net loss of at least RMB25.7 million for year	RE
25-09-29	Universal Health International Group Holding Limited Provides Consolidated Earnings Guidance for the Year Ended 30 June 2025	CI
25-07-31	Universal Health International to increase authorised share capital of co to $50 million	RE
25-07-04	Universal Health International Shareholders to Vote on HK$24.4 Million Share Sale	MT
25-05-14	Universal Health International to Raise HK$24.4 Million from Share Issue	MT
25-05-13	Universal Health International Says Co To Allot & Issue 304.4 Million Existing Shares	RE
25-04-29	Universal Health International Proposes Share Consolidation	RE
25-02-25	Universal Health International Group's H1 Loss Shrinks	MT
25-02-25	Universal Health International Group Holding Limited Reports Earnings Results for the Half Year Ended December 31, 2024	CI
24-11-19	Universal Health International Unit Buys Stake in Hollow Capsule Manufacturer	MT

23-05-02	Sierra Leone steps up capacity for health emergencies and disaster preparedness	AQ
23-05-02	Sierra Leone steps up capacity for health emergencies and disaster preparedness Sierra Leone is the first country in West Africa, the second in Africa and the fifth globally to undertake the pilot of this review	AQ
22-12-19	WHO Director-General's Opening Remarks At Member States Information Session On the Universal Health and Preparedness Review - 14 December 2022 [press release]	AQ
22-05-19	Ensuring Universal Health Coverage in Gombe	AQ
21-07-02	Universal Health International : Bill Due in September	AQ

Manager	Title	Age	Since
Chuan Fu Chu CEO	Chief Executive Officer	55	2012-03-11
Ze Hua Zhao DFI	Director of Finance/CFO	58	2011-09-30
Kit Ying Hui SEC	Corporate Secretary	-	2023-09-27

Director	Title	Age	Since
Dong Kun Jin BRD	Director/Board Member	53	2012-03-11
Sheung Hing Cheng BRD	Director/Board Member	79	2013-11-17
Su Hui Chiang BRD	Director/Board Member	80	2013-11-17

UNIL HEALNPV Stock Hong Kong S.E.

Stocks

2988

KYG9302L1361

Drug Retailers

Valuation: UNIL HEALNPV

Latest news : UNIL HEALNPV

Press Releases: UNIL HEALNPV

Managers and Directors: UNIL HEALNPV

Other Drug Retailers

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
UNIL HEALNPV	-.--%	-.--%	-	-	9.16M
JD HEALTH INTERNATIONAL INC.	+1.04%	+0.10%	-41.55%	-5.81%	15.65B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	0.00%	-2.11%	-39.50%	-23.95%	6.71B
MATSUKIYOCOCOKARA & CO.	+1.35%	+0.22%	-19.53%	-14.49%	6.13B
YIFENG PHARMACY CHAIN CO., LTD.	0.00%	-2.60%	+0.54%	-24.21%	4.31B
NAHDI MEDICAL COMPANY	+0.38%	-3.06%	-18.80%	-39.65%	3.22B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	+0.79%	-5.04%	+4.55%	-36.71%	3.02B
CLICKS GROUP LIMITED	+0.16%	-2.83%	-43.17%	-22.92%	3.01B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	-0.86%	-0.86%	-13.07%	-4.14%	2.61B
GUARDIAN PHARMACY SERVICES, INC.	+0.74%	-2.99%	+54.23%	-	2.42B
Average	+0.36%	-2.70%	-12.92%	-21.49%	5.23B
Weighted average by Cap.	+0.60%	-3.15%	-23.61%	-17.09%

	2024	2025
Net sales	1.09B 1.27B 161M 139M 131M 119M 224M 15.47B 228M 1.54B 603M 7.74B 606M 593M 25.78B	712M 828M 106M 91.13M 85.74M 77.93M 147M 10.11B 149M 1.01B 394M 5.06B 396M 388M 16.84B
Net income	413K 480K 61.24K 52.9K 49.77K 45.23K 85.08K 5.87M 86.32K 584K 229K 2.93M 230K 225K 9.78M	-26.01M -30.25M -3.86M -3.33M -3.13M -2.85M -5.36M -369M -5.44M -36.76M -14.41M -185M -14.48M -14.16M -616M
Net Debt	33.68M 39.17M 4.99M 4.31M 4.06M 3.69M 6.94M 478M 7.04M 47.6M 18.65M 239M 18.75M 18.34M 797M	11.14M 12.96M 1.65M 1.43M 1.34M 1.22M 2.29M 158M 2.33M 15.75M 6.17M 79.17M 6.2M 6.07M 264M